FDA cracks down on hydrocone products

Published: Sept. 29, 2007 at 1:31 AM

WASHINGTON, Sept. 29 (UPI) -- The U.S. Food and Drug Administration says it will start taking enforcement action against companies marketing unapproved hydrocodone products.

About 200 cough-suppressant products on the market will be impacted, the FDA said Friday in a release.

Hydrocodone, a narcotic widely used to treat pain and suppress coughs, can lead to serious illness, injury or death if improperly used.

While some hydrocodone-relief products such as Vicodin are FDA-approved, most hydrocodone formulations now marketed to suppress coughs are not.

The agency said it is especially concerned about improper pediatric labeling of unapproved hydrocodone cough suppressants, and the risk of medication error involving the unapproved products. Dr. Steven K. Galson, director of the FDA's Center for Drug Evaluation and Research, said no hydrocodone cough suppressant has been established as safe and effective for children under 6.

© 2007 United Press International, Inc. All Rights Reserved.
Order reprints



Additional News Stories
Wickmayer discusses doping suspension (6 min)
CDC estimates 22M had H1N1, 3,900 died (50 min)
New Orleans Hornets fire Coach Byron Scott
Chicago students arrested after food fight
Intel to pay AMD $1.25B settlement
UPI NewsTrack Business
Crude oil prices slide hard Thursday
fark
Murder suspect tells jury he has the cure for global warming, knows how to win in Afghanistan, and...
...and when they covered the Jews' cars in sticky-notes I said nothing, because I was not a Jew
Photoshop this barrier balancer
You can make your very own Tamiflu at home. I'm sure this will end well
Ohio couple married 61 years and died one day apart. There is no escape. Did you hear me? NO ESCAPE...
Elmo vs Spiderman vs Chewbacca: LA's superhero turf wars heat up again